Top

News & Events

Prosensa to Present at Wedbush 2013 Life Sciences Management Access Conference

Prosensa to Present at Wedbush 2013 Life Sciences Management Access Conference

Leiden, The Netherlands — August 6, 2013 — Prosensa Holding N.V. (NASDAQ: RNA) today announced that Hans GCP Schikan, Chief Executive Officer, will present a corporate overview at the Wedbush 2013 Life Sciences Management Access Conference in New York, NY on Tuesday, August 13, 2013 at 1:55pm ET. A live webcast of the presentation can be accessed through the Investor section of the Prosensa corporate website at http://ir.prosensa.eu/events.cfm and will be archived for 90 days.

 

Notes to Editors

About Prosensa Holding N.V.
Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington’s disease.
www.prosensa.com

Issued for and on behalf of Prosensa.

To contact the Prosensa team at College Hill, email prosensa@collegehill.com.

back to news

People

Sue CharlesManaging Partner

Melanie Toyne-SewellManaging Partner